Pericardial effusion may be found in as many as 30% of adult patients with hypothyroidism.' It appears to be a very rare finding in paediatric practice since only one child with this condition has been reported. 2 We report another case of a hypothyroid child with a pericardial effusion and outline the successful medical management.
Case report A 14 year old child with Down's syndrome was referred to us with signs and symptoms of severe hypothyroidism. His bone age was only 6 years while the thyroid function tests gave the following results: serum thyroxine concentration, 20 nmol/l (15-5 jLg/l) (normal 70-170 nmol/l; 54-3-132 1 jLg/l); serum triiodothyronine concentration 0-2 nmol/l (13-0 ng/dl) (normal 1-2-5 nmol/l; 65 1-162-7 ng/dl); serum triiodothyronine uptake 83% (normal 85-115%); and thyroid stimulating hormone concentration 40 mU/l (normal 0-8 mU/l). The history suggested that the condition had been long standing. The child was lethargic but not ill, and no abnormal cardiovascular signs were noticed on the initial examination except that the heart sounds were quiet. A chest radiograph was not performed at that time.
He was treated with 25 ,g thyroxine sodium a day with definite clinical improvement and the dose was increased to 50 ,ug a day after eight weeks. After this increment, he complained of shortness of breath and tiredness, which disappeared on reducing the dose to 25 ig a day. Two weeks later he suddenly became severely short of breath and had central chest pain. He had recovered by the time he was brought to hospital.
On examination the apex beat could not be palpated, the heart sounds were very quiet, but there was no pericardial rub. A chest x ray film showed a large globular heart suggesting a pericardial effusion ( Fig. 1 ) and the electrocardiogram showed low voltage in every lead with electrical alternans. The pericardiothoracic ,ratio was 0-7 1. An echocardiogram confirmed the presence of a large pericardial effusion (Fig. 2) . The patient appeared remarkably well despite such a massive effusion, and since there was no evidence of tamponade medical treatment was continued. The dose of thyroxine was slowly increased and no further cardiovascular symptoms occurred. After seven months of treatment, the heart remained very large (cardiothoracic ratio 0O65). Two months later, the heart size had returned to normal (cardiothoracic ratio 0 42), and the electrocardiogram was normal. An echocardiogram showed that the effusion had completely resolved.
The biochemical tests still showed mild hypothyroidism, however, although he was clinically euthyroid. His serum thyroxine concentration was 63 nmol/l (48-9 [tg/l) and his thyroid stimulating hormone concentration 9 5 mU/l.
He remained asymptomatic and a month later, after an increase of the dose of thyroxine to 125 mg a day, thyroid function tests showed no abnormalities.
Discussion
The only previous paediatric case report of juvenile hypothyroidism with pericardial effusion occurred in a 12 year old with Down's syndrome.2 Down's syndrome is known to be associated with thyroid disorders. In our patient the effusion was probably present at the Williams, ayatunga, Scott initial examination of the child but was not detected on clinical examination. Dyspnoea developed as the dose of thyroxine was increased but disappeared when the dose was reduced. Two weeks later dramatic symptoms prompted the cardiac assessment which showed the effusion. There was no tamponade despite the enormous effusion, and this is presumably because the fluid accumulated so slowly. The effusion resolved slowly over 10 months with treating with thyroxine only.
Our management is in accord with the findings of Ivy and Smolar et al who found that resolution occurred during thyroxine replacement therapy.34 Rasmussen et al in a juvenile2 and Ivy and Smolaret al in adults3 4 found that after drainage the pericardial effusion recurred and regressed only after thyroxine treatment.
We conclude that other hypothyroid children with less obvious cardiomegaly might have pericardial effusions which would only be recognised by echocardiography. If an effusion is found thyroxin replacement should be started with a small dose and increased very gradually in order to avoid the need to reduce the dose at any stage. Thyroid replacement alone will result in the resolution of the effusion, although it may take many months. Pericardiocentesis is unnecessary unless cardiac tamponade occurs. 
